Clinical Trials Browser

Completed × Carcinoma, Neuroendocrine × Temozolomide × Clear all

NCT03079440 2022-12-06

TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors

Phase 2 Completed

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT02248012 2019-12-19

Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)

Phase 2 Completed

Carcinoma, Neuroendocrine